Kiri

Saatja: <[email protected]> Saadetud: 31.05.2023 13:47 Teema: WHO: C.L.18.2023 (INN recommended list 89) Manused: C.L.18.2023 (recommended INN list 89) Arabic.pdf; C.L.18.2023 (recommended INN list 89) Chinese.pdf; C.L.18.2023 (recommended INN list 89) English.pdf; C.L.18.2023 (recommended INN list 89) French.pdf; C.L.18.2023 (recommended INN list 89) Russian.pdf; C.L.18.2023 (recommended INN list 89) Spanish.pdf Dear Member States of the World Health Organization, Please find attached, in the six official languages, C.L.18.2023 regarding the list 89 of international nonproprietary names recommended by the World Health Organization. Best regards, Department of Governing Bodies World Health Organization ***DO NOT RESPOND TO THIS E-MAIL. YOU WILL NOT RECEIVE A REPLY*** 20, AVENUE APPIA – CH-1211 GENEVA 27 – SWITZERLAND – TEL CENTRAL +41 22 791 2111 – FAX CENTRAL +41 22 791 3111 – WWW.WHO.INT Ref.: C.L.18.2023 The World Health Organization presents its compliments and has the honour to forward herewith, in accordance with Articles 3.A and 7 of the “Procedure for the Selection of Recommended International Nonproprietary Names for Pharmaceutical Substances” adopted by the Executive Board in its resolution EB15.R7,1 a list of names which has been published as International Nonproprietary Names recommended by the World Health Organization (abbreviation Rec. INN)2 on the WHO website at https://www.who.int/teams/health-product- and-policy-standards/inn/inn-lists. In accordance with Article 8 of the above-mentioned Procedure, the World Health Organization requests that the above-mentioned list of names be recognized as the nonproprietary names for the substances in question, and that the necessary steps be taken to prevent the acquisition of proprietary rights in the names, including prohibition of registration of the names as trademarks or tradenames. GENEVA, 31 May 2023 1 Annex to resolution EB15.R7, Off. Rec. Wld Hlth Org., No. 60, pp. 3 and 55. This text was amended by resolution EB43.R9, Off. Rec. Wld Hlth Org., No. 173, p. 10 and resolution EB115.R4, Executive Board, 115th Session, Resolutions and Decisions (EB115/2005/REC/1), p. 2. 2 Rec. INN: List 89 published in WHO Drug Information, Vol. 37, No.1, 2023.